We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: -0.05 (-4.55%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.10
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

5 Feb 2021 08:01

RNS Number : 0851O
Microsaic Systems plc
05 February 2021
 

 

5 February 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board changes

Microsaic (AIM: MSYS), the point-of-need mass spectrometry company, is pleased to announce that, further to the fundraise announcements on 19 January 2021 and the passing of the resolutions at the General Meeting held yesterday, Gerard Brandon and Dr Nigel Burton are appointed to the Board of the Company as Non-Executive Chairman and Non-executive Director respectively, with effect from 8.00 a.m. today.

The Finance & Audit and Remuneration Committees will be chaired by Dr. Nigel Burton, and Gerard Brandon will be a member of both committees. Dr. Nigel Burton will assume the responsibilities of Senior Non-Executive Director. These arrangements will be reviewed when an independent Non-executive Director joins the Board.

 

Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc ("Alltracel"), where he built a team which oversaw numerous patents granted on refined cellulose. Alltracel was admitted to trading on AIM in 2001. In 2004, he was appointed as a Managing Partner for Farmabrand Private Equity. In March 2020, he was appointed as a Non-executive Chairman to Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020. Gerard is a Fellow of the Ryan Academy of Entrepreneurs in Dublin.

Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc.

As anticipated in the Circular published on 19 January 2021, Peter Grant, Non-executive Chairman and Eric Yeatman, Non-executive Director, stepped down from the Board with effect from 8.00 a.m. today. Eric Yeatman will be retained as a consultant.

Gerard Brandon, Chairman, said:

"Nigel and I are delighted to be joining the Board and look forward to working with, and supporting, management to commercialise the amazing technology built over the last 19 years. Investing in the recent Placing and taking our respective Director fees only in shares, we have full confidence for the future of Microsaic.

The Company would also like to take this opportunity to thank Peter Grant for his contribution as Chairman over the past three years and Professor Eric Yeatman for his contribution as one of the original founders of the Company and a Director since 2001. We are pleased to be retaining Eric as a consultant to the Company given his expert knowledge of the Company's technology and business."

 

Enquiries:

Microsaic Systems plc

 

 

 

Glenn Tracey, CEO

+44 (0) 1483 751 577

Bevan Metcalf, FD

 

 

N+1 Singer

 

+44 (0) 20 7496 3000

(Nominated Adviser and Joint Broker)Aubrey Powell / George Tzimas / Tom Salvesen

 

 

Turner Pope Investments (TPI) Limited (Joint Broker)

+44 (0) 20 3657 0050

Zoe Alexander / Andy Thacker

 

 

 

In accordance with obligations under the AIM Rules Schedule 2(g), Gerard James Brandon, 59, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships

Innovenn UK Ltd

Visible Youth Limited

Deepverge plc (nee Integumen plc)

VY Club Ltd

Pursuit Marine Drive Ltd

Cellulac plc

Cellulac Trading Ltd

Rincloud Ltd

Modern Water plc

Parity Group plc

Integumen Ltd

LifescienceHub UK Limited

AER Sustainable Energy Limited

LifescienceHub Ireland Limited

Integumen Ireland Limited

Stoer Ireland Limited

 

In accordance with obligations under the AIM Rules Schedule 2(g), Dr. Nigel John Burton, 62, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships

Wasdale Head Limited

Management Resource Solutions plc

Wasdale Head Inn Limited

Nu-Oil and Gas plc

SenseToys Limited

Remote Monitored Systems plc

ASD Visual Aids Limited

GyroMetric Systems Limited

Digitalbox plc

Strat Aero International Limited

Tau Capital plc

UKAerovision Limited

Energy Group plc

Corcel plc

Mobile Streams plc

Streams Data Limited

Mobile Streams Inc

Modern Water plc

eEnergy Holdings Limited

DeepVerge plc

Blackrock Throgmorton Trust plc

 

 

Dr Burton was a director of Pease Limited within the 12 months prior to the company appointing a liquidator in June 1998. The company was subsequently liquidated in 2002.

 

There is no further information to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

Dr. Burton currently holds 500,000 ordinary shares in Microsaic Systems plc. A separate announcement is today being made confirming the interests of Mr. Brandon and Dr. Burton following completion of the fundraising for the Company.

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company which develops point-of-need mass spectrometers (MS) designed to improve the efficiency of chemical and biological workflows.

The Company was initially established to develop miniaturised MS instruments based on micro-electromechanical systems (MEMS) technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. Since being established in 2001, the Company has invested substantially in core intellectual property specific to its miniaturised MS, with over 60 patents in chip based, compact MS.

The Company has sold over 160 instruments to date and has signed over ten commercial partners, including in North America, Europe, China, SE Asia and Japan, with the majority of signings occurring in 2018 and 2019. For more information, please go to www.microsaic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATIMTTMTBMTFB
Date   Source Headline
27th Mar 20248:49 amRNSCompany Update
16th Feb 20247:00 amRNSCompany Update
25th Jan 20247:00 amRNSCompletion of Acquisition
23rd Jan 20241:30 pmRNSHolding(s) in Company
18th Jan 20246:15 pmRNSHolding(s) in Company
18th Jan 20243:15 pmRNSHolding(s) in Company
18th Jan 202412:00 pmRNSHolding(s) in Company
18th Jan 202410:05 amRNSHolding(s) in Company
16th Jan 20247:30 amRNSRestoration - Microsaic Systems PLC
16th Jan 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSFinal Results
16th Jan 20247:00 amRNSRestoration & Update
15th Jan 20243:45 pmRNSConditional Placing
12th Jan 20244:15 pmRNSAcquisition, Update & Change of Registered Office
4th Jan 20247:00 amRNSUpdate
29th Dec 202311:41 amRNSResult of General Meeting
22nd Dec 20231:27 pmRNSAcquisition & Fundraise Update, Revised Timetable
20th Dec 20233:03 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
20th Dec 202312:30 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
14th Dec 20237:00 amRNSUpdate on Financing, GM & Prospective Acquisition
4th Dec 20237:00 amRNSPublication of Circular and Notice of GM
13th Nov 20238:42 amRNSFunding Update
6th Nov 20237:00 amRNSFunding & Operational Update, Intention to Delist
3rd Nov 20231:32 pmRNSFunding & Operational Update, Intention to Delist
25th Sep 20237:00 amRNSUpdate and Directorate change
3rd Jul 20237:30 amRNSSuspension - Microsaic Systems PLC
29th Jun 20234:00 pmRNSAnnual Financial Report
26th Jun 20237:15 amRNSDeepVerge: debtor update
15th May 20237:15 amRNSAudit update
18th Apr 20237:59 amRNSDeepVerge plc debtor
13th Mar 202310:10 amRNSHolding(s) in Company
28th Dec 20229:25 amRNSHolding(s) in Company
24th Nov 20222:05 pmRNSSecond Price Monitoring Extn
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.